A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy
2017 · Nature · 647 citations
https://doi.org/10.1038/nature24473
A
Alexander Solovyov
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
133
Papers
4.5K
Citations
22
h-index
30
i10-index
Alexander Solovyov is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer-related Molecular Pathways & COVID-19 and healthcare impacts & Multiple and Secondary Primary Cancers. The author has an h-index of 22, co-authored 114 publications.
ORCID: 0000-0002-7682-4706Papers by this author
worksDengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection
2017 · Nature Microbiology · 368 citations
https://doi.org/10.1038/nmicrobiol.2017.37
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer
2025 · Nature · 61 citations
https://doi.org/10.1038/s41586-024-08426-5
Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
2022 · Cancer Discovery · 57 citations
https://doi.org/10.1158/2159-8290.cd-21-1117
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1
2022 · iScience · 48 citations
https://doi.org/10.1016/j.isci.2022.104599
Chronic Viral Mimicry Induction following p53 Loss Promotes Immune Evasion
2025 · Cancer Discovery · 15 citations
https://doi.org/10.1158/2159-8290.cd-24-0094
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat